Takamizawa Junichi, Konishi Hiroyuki, Yanagisawa Kiyoshi, Tomida Shuta, Osada Hirotaka, Endoh Hideki, Harano Tomoko, Yatabe Yasushi, Nagino Masato, Nimura Yuji, Mitsudomi Tetsuya, Takahashi Takashi
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Cancer Res. 2004 Jun 1;64(11):3753-6. doi: 10.1158/0008-5472.CAN-04-0637.
In this study, we report for the first time reduced expression of the let-7 microRNA in human lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative resection could be classified into two major groups according to let-7 expression in unsupervised hierarchical analysis, showing significantly shorter survival after potentially curative resection in cases with reduced let-7 expression (P = 0.0003). Multivariate COX regression analysis showed this prognostic impact to be independent of disease stage (hazard ratio = 2.17; P = 0.009). In addition, overexpression of let-7 in A549 lung adenocarcinoma cell line inhibited lung cancer cell growth in vitro. This study represents the first report of reduced expression of let-7 and the potential clinical and biological effects of such a microRNA alteration.
在本研究中,我们首次报道了人类肺癌中let-7微小RNA表达降低的情况。有趣的是,在无监督层次分析中,143例接受了潜在根治性切除术的肺癌病例可根据let-7表达分为两大组,let-7表达降低的病例在潜在根治性切除术后的生存期明显缩短(P = 0.0003)。多变量COX回归分析表明,这种预后影响独立于疾病分期(风险比 = 2.17;P = 0.009)。此外,在A549肺腺癌细胞系中过表达let-7可在体外抑制肺癌细胞生长。本研究首次报道了let-7表达降低以及这种微小RNA改变的潜在临床和生物学效应。